Results 91 to 100 of about 3,264 (192)
Increased Levels of the Bullous Pemphigoid BP180 Autoantibody Are Associated with More Severe Dementia in Alzheimer's Disease [PDF]
, 2016 Bullous pemphigoid (BP) is a subepidermal blistering skin disease, which has shown a strong association with neurological diseases in epidemiological studies.
Huilaja, Laura +7 more
core +1 more source
Case Reports in Dermatology, 2013 Lichen planus pemphigoides (LPP) is a rare clinical variant of bullous pemphigoid (BP). A 35-year-old female patient presented to our hospital complaining of pruritic violaceous-colored plaques or papules on the extremities. Tense vesicles were also seen
Ken Washio +4 more
doaj +1 more source
, 2017 Bullous pemphigoid (BP) is by far the most frequent autoimmune blistering disease. The presence of IgE autoantibodies against the transmembrane protein BP antigen 2 (BP180, type XVII collagen) has previously been reported in 22% to 100% of BP serum ...
Recke, Andreas +7 more
core +1 more source
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
Frontiers in Immunology, 2018 Mucous membrane pemphigoids (MMPs) and bullous pemphigoid (BP) are autoimmune bullous diseases that share physiopathological features: both can result from autoantibodies directed against BP180 or BP230 antigens.
Olivier Gaudin +14 more
doaj +1 more source
Foot-and-Mouth Disease Virus 3Cpro Cleaves BP180 to Induce Blister Formation
, 2022 Foot-and-mouth disease (FMD) is mainly characterized by blister formation (vesicles) in animals infected with foot-and-mouth disease virus (FMDV). However, the molecular basis of the blister formation in FMD is still unknown.
Jong-Soo Lee (194708) +4 more
core
Shedding of Collagen XVII/BP180 [PDF]
Journal of Biological Chemistry, 2004 Claus-Werner Franzke +4 more
openaire +1 more source
Frontiers in MedicineObjectiveThis study aimed to explore the relationship between serum levels of interleukin-17 (IL-17), interleukin-18 (IL-18), interleukin-22 (IL-22), interleukin-25 (IL-25), anti-BP180 antibodies, anti-BP230 antibodies, and immunoglobulin E (IgE) and the
Xinyi Hong +23 more
doaj +1 more source
Bullous Wells’ syndrome successfully treated with omalizumab
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 5, Page 657-659, May 2026.
Giulia Ciccarese +7 more
wiley +1 more source
Journal of General and Family MedicineWe report the case of an 82‐year‐old male with a history of multiple cerebral infarctions who developed bullous pemphigoid while receiving home‐based care.
Hiromitsu Yamashita +3 more
doaj +1 more source
Frontiers in ImmunologyBackgroundA novel fully automated chemiluminescent immunoassay (CLIA) has been developed to quantify autoantibodies specific for desmogleins (Dsg1, Dsg3), BP180, and BP230, key target antigens in pemphigus and bullous pemphigoid.
Na Zhang +14 more
doaj +1 more source